Patent · US Expired

Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof

US7183279B2 · kind B2 · utility

0Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 25, 2006
Grant dateFeb 27, 2007
Priority date
Expiry dateMay 25, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K5/126
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to new basic amino acid derivatives of general formulae I, II and III, and the preparation and use thereof in treatment of pain. The compounds have histogranin-like antinociceptive, morphine potentiating and COX-2 induction modulating activities.wherein:A is -hydrogen, —(C1–C8)alkyl or —(C1–C8)alkyl substituted by hydroxy;B is —(C1–C6)alkylguanidino, —(C1–C6)alkyl(4-imidazolyl), —(C1–C6)alkylamino, p-aminophenylalkyl(C1–C6)—, p-guanidinophenylalkyl(C1–C6)— or 4-pyridinylalkyl(C1–C6)—;D is —(CO)—, —(CO)—(C1–C6)alkylene or —(C1–C6)alkylene;E is a single bond or —(C1–C6)alkylene;Z is —NH2, —NH—(C1–C6)alkylcarboxamide, —NH— (C1–C6)alkyl, —NH— (N-benzyl), —NH-cyclo (C5–C7)alkyl, —NH-2-(1-piperidyl)ethyl, —NH-2-(1-pyrrolidyl)ethyl, —NH-2-(1-pyridyl)ethyl, —NH-2-(morpholino)ethyl, -morpholino, -piperidyl, —OH, —(C1–C6)alkoxy, —O-benzyl or —O-halobenzyl;R1, R2 and R3 are, independent of one another, -hydrogen, -arylcarbonylamino, —(C1–C6)alkoylamino, —(C1–C6)alkylamino, —(C1–C6)alkyloxy, —(C1–C6)alkylaminocarbonyl, -carboxy, —OH, -benzoyl, -p-halogenobenzoyl, -methyl, —S-(2,4-dinitrophenyl), —S-(3-nitro-2-pyridinesulfenyl), -sulfonyl, -trifluoromethyl, —(C1–C6)alkylam…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.